A common misconception is the belief that finished product testing is sufficient to demonstrate quality. However, facilities that perform…
Testing Alone is not Enough
A common misconception is the belief that finished product testing is sufficient to demonstrate quality. However, facilities that perform…
Apr, Thu, 2019
A Summary of Proposed Changes to USP 797
Some of the changes are significant and will require major adjustments in pharmacy systems and processes, while other changes will be easier to accommodate.
A Summary of Proposed Changes to USP 797
Some of the changes are significant and will require major adjustments in pharmacy systems and processes, while other changes will be easier to accommodate.
Apr, Fri, 2019
Insanitary Conditions in Compounding Pharmacies: The Regulatory Framework
In the wake of the 2012 tragedy caused by contaminated drugs produced at the New England Compounding Center, Congress…
Insanitary Conditions in Compounding Pharmacies: The Regulatory Framework
In the wake of the 2012 tragedy caused by contaminated drugs produced at the New England Compounding Center, Congress…
Dec, Tue, 2018
The Compounder’s Crash Course to FDA and 503A Exemption Audits
The Compounder’s Crash Course to FDA and 503A Exemption Audits Hosted by Eagle Analytical Services If your pharmacy were inspected by the FDA, would you be prepared?
The Compounder’s Crash Course to FDA and 503A Exemption Audits
The Compounder’s Crash Course to FDA and 503A Exemption Audits Hosted by Eagle Analytical Services If your pharmacy were inspected by the FDA, would you be prepared?
Dec, Tue, 2018
What to Test – When to Test – Why to Test
Join Eagle CEO, Dr. Ross Caputo as he shares the testing requirements for your compounding facility: helping you navigate the “what, when & the why’s” of testing.
What to Test – When to Test – Why to Test
Join Eagle CEO, Dr. Ross Caputo as he shares the testing requirements for your compounding facility: helping you navigate the “what, when & the why’s” of testing.